interleukin receptor activates myd88-arno-arf6 cascade disrupt vascular stability 
innate immune response essential combating infectious disease macrophages cells respond infection releasing cytokines interleukin- beta il- beta turn activate well-described myeloid-differentiation factor myd88-mediated nuclear factor-kappa b nf-kappa b-dependent transcriptional pathway results inflammatory-cell activation recruitment1- endothelial cells usually serve barrier movement inflammatory cells blood tissue also critical mediators inflammatory response56 paradoxically cytokines vital successful immune defence also disruptive effects endothelial cell-cell interactions can trigger degradation barrier function dissociation tissue architecture7- mechanism barrier dissolution relationship canonical nf-kappa b pathway remain poorly defined show direct immediate disruptive effects il- beta endothelial stability human vitro cell model nf-kappa b independent instead result signalling small gtpase adp-ribosylation factor arf6 activator arf nucleotide binding site opener arno; also known cyth2 moreover show arno binds directly adaptor protein myd88 thus propose myd88-arno-arf6 proximal il- beta signalling pathway distinct mediated nf-kappa b finally show secinh3 inhibitor arf guanine nucleotide-exchange factors arno enhances vascular stability significantly improves outcomes animal models inflammatory arthritis acute inflammation 
